TickerSutra

NSE: FINEORG · BSE: 541557 · ISIN INE686Y01026

Fine Organic Industries Limited stock analysis

Fine Organic Industries Limited ranks #544 in the TickerSutra evidence-ranked universe with a score of 63/100 and 95% data confidence. The latest captured fundamentals show ROCE of 21.5%, quarterly sales growth of 18.0% and quarterly profit growth of 23.4%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE63/100

Monitor only

#544 of 5,430 ranked equities
Market capitalisation₹15,936.68cr
ROCE21.5%
Quarterly sales growth18.0%
Quarterly profit growth23.4%
P/E ratio36.4×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • ROCE is 21.5%
  • Low debt/equity of 0.03×
  • Strong CFO/EBITDA of 0.9×
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • No calculated threshold risk in the current snapshot.

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹1,876cr₹363cr₹260cr19.0%
2023₹3,023cr₹829cr₹618cr27.0%
2024₹2,123cr₹532cr₹412cr25.0%
2025₹2,269cr₹512cr₹410cr23.0%
2026₹2,366cr₹480cr₹417cr20.0%
TTM₹2,472cr₹531cr₹438cr21.0%
Debt / equity0.03×
CFO / EBITDA0.90×
Operating margin21.0%
Free cash flow₹288cr
Sales CAGR · 3Y-7.8%
Profit CAGR · 3Y-12.3%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

1 positive catalysts0 negative catalysts3 routine filings

MANAGEMENT COMMENTARY

Signals from filed documents

Capacity expansion plansHigh severity · 9 mentions
Positive catalyst

Commissioned the large-scale manufacturing facility at Ambernath, further enhancing manufacturing capabilities and supporting business growth. Initiated exports and undertook phased capacity expansions across manufacturing facilities to meet growing domestic and international demand. Consolidating for the Future Strengthened operational capabilities across manufacturing locations to enhance efficiency, reliability, a

Operating leverageHigh severity · 2 mentions
Positive catalyst

This balanced revenue mix enabled the Company to maintain continuity of operations and sustain production levels across its manufacturing facilities. Manufacturing assets operated at optimal utilisation levels throughout the year, supporting consistent revenue generation and efficient cost absorption. Profitability remained healthy, reflecting continued focus on operational efficiency and prudent cost management.

Margin pressureHigh severity · 1 mention
Risk easing

The chemicals industry experienced mixed trends across regions. Demand conditions improved gradually in select end- user industries, though margin pressures persisted due to fluctuations in raw material and energy costs. Sustainability- led regulations, particularly in Europe and North America, accelerated the transition towards bio-based, eco-friendly, and specialty performance products.

Export market updatesHigh severity · 7 mentions
Constructive

The development at the site is being undertaken in a phased and disciplined manner. The proximity of the site to one of India’s largest ports supports improved logistics efficiency and strengthens supply chain connectivity for serving international markets. Moving Closer to Global Markets As global supply chains continue to evolve, proximity to customers has become increasingly important.

Raw material inflationHigh severity · 1 mention
Risk easing

Collectively, these developments are likely to create a more balanced supply-demand environment and improve feedstock price stability. As Fine Organics generally passes on raw material cost movements with an appropriate time lag, a more stable input cost environment is expected to support margin normalisation, enhance pricing visibility and improve operational planning. 2 Domestic reforms reshaping cost structures In

Product approvalsHigh severity · 6 mentions
Positive catalyst

n Competitive Risk: Risk: Intensifying competition within the specialty chemicals sector. Mitigation: Strong entry barriers supported by proprietary technologies, global product approvals, and in-house engineering capabilities sustain the Company’s competitive edge. n Commodity Price Risk: Risk: Volatility in key raw material prices and energy costs.

Regulatory updatesModerate severity · 62 mentions
Constructive

Government initiatives aimed at improving manufacturing competitiveness and promoting chemical infrastructure are further strengthening the sector. India is well-positioned to benefit from global supply chain diversification due to its skilled workforce, improving infrastructure, and strong regulatory compliance standards. Increasing environmental regulations globally are also creating export opportunities for Indian

Capacity commissioningModerate severity · 2 mentions
Positive catalyst

We are working actively on the JNPA project and project acquisition committee continues progress as per the scheduling. As communicated earlier, we expect the commencement of commercial production sometime during FY '28. Fine Organic Industries Limited May 21, 2026 Page 4 of 19 The SEZ facility remains a critical pillar of our long -term growth strategy and is expected to strengthen our export manufacturing capabilit

Management confidenceModerate severity · 1 mention
Constructive

Overall, the near -term global environment continues to remain dynamic and uncertain. We remain confident about the long -term opportunities for the specialty additives industry and for Fine Organics. With that, I would now like to invite Ms.

Niche productsModerate severity · 3 mentions
Positive catalyst

The resulting global-local model enhances business stability and positions the Company as a trusted partner across markets. PRODUCT PORTFOLIO The Company’s technologically advanced portfolio comprises a wide range of specialised products, almost all derived from sustainable, plant-based feedstock. The range spans high- performance food emulsifiers, advanced polymer additives, premium personal care ingredients, and hi

Regulatory approvalLow severity · 19 mentions
Watch

Review various proposals and identify the eligible entities/agencies for allocation of CSR amount; 6. Spend the allocated CSR amount on the CSR activities once it is approved by the Board of Directors of the Company in accordance with the Act and the CSR Rules; 7. Monitor and review periodically the CSR activities and submit the reports to the Board in respect of the CSR activities undertaken by the Company; 8.

Pricing commentaryLow severity · 1 mention
Constructive

It's going to be very flat till the SEZ plant is commissioned. And even if you see some top line growth, it will be because of the price increase not because of any sales growth. Bharat Shah: And, So after FY'28, what kind of picture, Mukesh, do you think would prevail?

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…